European Journal of Neurology

Papers
(The H4-Index of European Journal of Neurology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Basal ganglia matter260
Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis133
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift128
What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse?101
Thank you to our peer reviewers in 202395
Possible benefit of second intravenous immunoglobulin course in Guillain−Barré syndrome patients with potentially poor prognosis91
Benefits of influenza vaccine on stroke beyond preventing infection: Paradigm change or sheer bias?90
Special Sessions87
Machine‐learning‐derived heart and brain age are independently associated with cognition84
Issue Information83
European Journal of Neurology will flip to open access in January 202482
Issue Information80
Spinal muscular atrophy: are small sensory fibres involved?76
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment76
Blood pressure variability and functional outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction76
Central nervous system crystal‐storing histiocytosis: A case report and literature review61
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease60
Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real‐word study on aducanumab and le60
Lyme neuroborreliosis in Japan: Borrelia burgdorferi sensu lato as a cause of meningitis of previously undetermined etiology in hospitalized patients outside of the island of Hokkaido, 2010–20256
The European Academy of Neurology NeuroCOVID‐19 Task Force: A lesson for the future55
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study53
Enhancing multisensory rehabilitation of visual field defects with transcranial direct current stimulation: A randomized clinical trial52
Issue Information52
Dorsolateral pontine lesions produce distinct ocular motor abnormalities with anatomical correlations52
Predictors of affective disturbances and cognitive impairment following small spontaneous supratentorial intracerebral hemorrhage51
Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study50
Complement activation by IgM autoantibodies linked to immune‐mediated neuropathies depends on C250
Small fiber neuropathy associated with COVID‐19 infection and vaccination: A prospective case–control study49
Cost‐utility analysis of a coadjutant telemedicine intervention for fall prevention in Parkinson's disease46
Postural control in episodic ataxia type 2: no evidence for increased vestibular excitability45
The presence and burden of cognitive issues: discordance between the perception of neurologists and people living with multiple sclerosis43
Prognostic Value of Signal Abnormalities on Brain MRI in Post‐Anoxic Super‐Refractory Status Epilepticus: A Single‐Center Retrospective Study42
Comparison of different surgical strategies for cervical dystonia: Evidence from Bayesian network analysis41
Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation41
Assessment of the available evidence for the use of 7‐Tesla (T) magnetic resonance imaging (MRI) in neurological and musculoskeletal disorders, with comparison to 3‐T 39
Neglected outcomes of cerebrovascular disorders in neuromuscular diseases39
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study39
A common marker of affect recognition dysfunction in the FTD spectrum of disorders39
CORRIGENDUM38
0.49340009689331